Similar articles for PMID: 28662283

Year	Number of Results
2014	1
2015	2
2016	19
2017	57
2018	99
2019	97
2020	55
2021	31
2022	16
2023	5
2024	0

1

Treatment of a patient with HIV and metastatic melanoma with consequitive ipilimumab and nivolumab.

Tomsitz D, Hein R, Biedermann T, Kohlmeyer J. Tomsitz D, et al. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e26-e28. doi: 10.1111/jdv.14450. Epub 2017 Jul 17. J Eur Acad Dermatol Venereol. 2018. PMID: 28662283 No abstract available.

2

Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus.

Maeda T, Yanagi T, Imafuku K, Kitamura S, Hata H, Izumi K, Ujiie H, Iwata H, Shimizu H. Maeda T, et al. Int J Dermatol. 2017 Dec;56(12):1477-1479. doi: 10.1111/ijd.13713. Epub 2017 Aug 1. Int J Dermatol. 2017. PMID: 28762466 No abstract available.

3

No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.

Takimoto R, Otsuka A, Kaku Y, Honda T, Kabashima K. Takimoto R, et al. Eur J Dermatol. 2018 Feb 1;28(1):84-85. doi: 10.1684/ejd.2017.3151. Eur J Dermatol. 2018. PMID: 29400292 No abstract available.

4

Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure.

Oya K, Nakamura Y, Fujisawa Y, Endo R, Tanaka R, Ishitsuka Y, Maruyama H, Watanabe R, Okiyama N, Fujimoto M. Oya K, et al. Eur J Dermatol. 2018 Feb 1;28(1):129-130. doi: 10.1684/ejd.2017.3192. Eur J Dermatol. 2018. PMID: 29400284 No abstract available.

5

Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia.

Maeda T, Hiura A, Uehara J, Toyoshima R, Nakagawa T, Yoshino K. Maeda T, et al. Eur J Dermatol. 2021 Oct 1;31(5):662-664. doi: 10.1684/ejd.2021.4139. Eur J Dermatol. 2021. PMID: 34642136 No abstract available.

6

Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?

Quéreux G, Wylomanski S, Bouquin R, Saint-Jean M, Peuvrel L, Knol AC, Hanf M, Dréno B. Quéreux G, et al. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e39-e40. doi: 10.1111/jdv.14486. Epub 2017 Aug 13. J Eur Acad Dermatol Venereol. 2018. PMID: 28750150 No abstract available.

7

Ipilimumab prolongs survival in advanced melanoma.

Burki TK. Burki TK. Lancet Oncol. 2016 Nov;17(11):e481. doi: 10.1016/S1470-2045(16)30501-0. Epub 2016 Oct 13. Lancet Oncol. 2016. PMID: 27746107 No abstract available.

8

Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.

Page B, Borradori L, Beltraminelli H, Yawalkar N, Hunger RE. Page B, et al. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e256-e257. doi: 10.1111/jdv.14282. Epub 2017 May 30. J Eur Acad Dermatol Venereol. 2018. PMID: 28430376 No abstract available.

9

Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.

Alnabulsi R, Hussain A, DeAngelis D. Alnabulsi R, et al. Orbit. 2018 Oct;37(5):381-384. doi: 10.1080/01676830.2017.1423349. Epub 2018 Jan 30. Orbit. 2018. PMID: 29381409

10

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.

McDonald MA, Sanghvi P, Bykowski J, Daniels GA. McDonald MA, et al. BMC Cancer. 2018 May 9;18(1):549. doi: 10.1186/s12885-018-4470-y. BMC Cancer. 2018. PMID: 29743050 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

316 results

Results by year